CCL2 and prediabetes syndrome: Taking into account these biochemical changes, we postulate that in prediabetes, moderate hyperglycemia alters the RAS, consequently promoting inflammation, as evidenced by the increased MCP-1 concentration in PD compared to NPD (see Figure 6).